Strategic Partnerships Asuragen has established strategic partnerships with key players in the industry like Oxford Nanopore Technologies, showcasing potential sales opportunities for collaborative projects and product offerings.

Innovative Product Launches Through consistent product launches such as the AmplideX Nanopore Carrier Plus Kit and cystic fibrosis gene test kits, Asuragen demonstrates a commitment to innovation, providing sales avenues for new product adoption in the market.

Industry Conference Presence Regular attendance and participation in major industry conferences like AMP 2022 and 2023 present prime opportunities for Asuragen to engage with potential customers, showcase solutions, and drive sales through networking and collaborations.

Advanced Sequencing Technology Asuragen's focus on developing advanced sequencing systems using PCR technology and long-read sequencing capabilities offers unique selling points for sales representatives aiming to target customers in need of high-precision genetic screening solutions.

Expanding Market Reach With a revenue range of $10M - $50M and continuous product development efforts, Asuragen is positioned to expand its market reach, providing sales professionals with opportunities to penetrate new segments and drive revenue growth.